SH-7139

N/A

Report date: 2025/01/26 16:12:22
NME

Base Information

Drug NameSH-7139
Drug Alias NameHLA-DR10 inhibitor (SHAL)SH-7139
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistocompatibility antigens class II inhibitors
TargetsHistocompatibility antigens class II
Therapy Area/IndicationsSolid tumoursLymphoma, B-CellLymphoma, Non-Hodgkin +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesShal Technologies
China Registration ClassN/A

Develop Information

Active CompaniesShal Technologies
Inactive CompaniesN/A
Active IndicationsSolid tumoursLymphoma, Non-Hodgkin
Inactive IndicationsLymphoma, B-CellNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A